Yanhua Hu

1PUBLICATIONS
4CO-AUTHORS
Pharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Sep 16, 2024
Pharmacodynamic Response to Deucravacitinib, an Oral, Selective, Allosteric TYK2 Inhibitor, in a Global, Phase 2, Randomized, Double-Blind, Placebo-Controlled Psoriasis Trial.

Ian M Catlett, Lu Gao, Yanhua Hu

Pageof 1

Frequent Collaborators

1 joint publications

Ian M Catlett

1 joint publications

Lu Gao

1 joint publications

Subhashis Banerjee

1 joint publications

James G Krueger